ALIE GEREN: Open Payments
NPI 1245605310 · OOLTEWAH, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$883 in 40 payments from 19 companies in 2025. Trend: 2023 $724 · 2024 $569 · 2025 $883
Food & beverage: $883
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 9 | $231 |
| Boston Scientific Corporation | 2 | $97 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 5 | $86 |
| GlaxoSmithKline, LLC. | 5 | $84 |
| Abbott Laboratories | 3 | $71 |
| Xeris Pharmaceuticals, Inc. | 2 | $48 |
| Radius Health, Inc. | 1 | $34 |
| Janssen Pharmaceuticals, Inc | 1 | $32 |
| Inspire Medical Systems, Inc. | 2 | $32 |
| Optinose US, Inc. | 1 | $23 |
Products named: Rybelsus, WaveWriter Alpha Prime 16, Ozempic, CAPLYTA, SHINGRIX, FREESTYLE LIBRE 3, GVOKE HYPOPEN, Tymlos.
Industry payments across TN — which companies pay providers there.
